Shareholders Equity: The sum of preferred and common equity items.
Aspen Pharmacare (APNHY) had Shareholders Equity of $4.76B for the most recently reported fiscal year, ending 2026-06-30.
| Income Statement Financials | |
$2.06B |
|
$156.70M |
|
$1.23B |
|
$832.06M |
|
$2.02B |
|
$45.17M |
|
$-69.92M |
|
$-24.75M |
|
$-24.75M |
|
$-52.57M |
|
$-52.57M |
|
$156.70M |
|
$-52.57M |
|
$45.17M |
|
$45.17M |
|
444.10M |
|
444.10M |
|
$0.35 |
|
$0.35 |
|
| Balance Sheet Financials | |
$2.44B |
|
$1.20B |
|
$3.97B |
|
$6.41B |
|
$960.52M |
|
$562.22M |
|
$691.34M |
|
$1.65B |
|
-- |
|
$2.19B |
|
|
Shareholders Equity |
$4.76B |
-- |
|
| Cash Flow Statement Financials | |
$406.64M |
|
$1.44B |
|
$-1.26B |
|
$379.41M |
|
$945.72M |
|
$566.31M |
|
-- |
|
$-55.71M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|